Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections

Part of paid clinical trials in Lansing, Michigan.

Sponsor
OsteoRemedies, LLC
Study ID
NCT06428448
Phase
PHASE2
Status
Recruiting

Conditions

  • Periprosthetic Joint Infection

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • REMEDY Spectrum IM Spacer Nail — COMBINATION_PRODUCT
    The REMEDY SPECTRUM IM Spacer Nail is a single-use implant made of polymethylmethacrylate (PMMA) which is internally reinforced with a stainless-steel core (ASTM F138, ISO 5832-1). The PMMA of the REMEDY SPECTRUM IM Spacer Nail is laden with gentamicin and vancomycin. The nail has a slot at the distal end and can be combined with the surgeon's choice of fixation to prevent migration depending on the anatomy of the patient. The REMEDY SPECTRUM IM Spacer Nail is available in two lengths (150mm and 300mm) to accommodate variations in patient anatomy. The distal end has a threaded recess for mating with the optional distal cap, as well as the insertion and removal tools.

Study Details

This study is being conducted to evaluate the safety and effectiveness of the REMEDY SPECTRUM IM Spacer Nail in the treatment of ankle-related infections. The study is expected to take approximately 18 months from first subject enrolled to the last follow-up visit. It will have a 12-month enrollment period and a 6-month follow-up. This study is a Prospective, multicenter, single-arm clinical trial. All subjects enrolled in this study will receive the REMEDY SPECTRUM IM Spacer Nail.

Key Dates

Start date
Feb 1, 2026
Status verified
May 2026
Primary completion
Aug 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
60 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Subjects with REMEDY Spectrum IM Spacer Nail
    This is the REMEDY Spectrum IM Spacer Nail treatment group.

Primary Outcome Measure

Successful Treatment of Infection Based on Lab Values and Culture [ Time Frame: 6 months ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
University of Michigan Health - Sparrow Clinical Research InstituteLansingMichigan48190
Jennifer Boak
517-364-5733
Jessica Bristol-Piper
517-364-5728
Karl Dunn (PRINCIPAL_INVESTIGATOR)
OrthoCarolina Research InstituteCharlotteNorth Carolina28207
Zachary Hutchko
704-323-2556
Caleb Michalek
7043233698
Carroll Jones (PRINCIPAL_INVESTIGATOR)
Duke University Medical CenterDurhamNorth Carolina27710
Caroline Darragh
919-613-3670
Karl Murawski (PRINCIPAL_INVESTIGATOR)

Find similar trials in Lansing, MI

Related Studies